Table 2 Treatments and dosimetric features
CK hFSRT | nFSRT | p-value | |
|---|---|---|---|
GTV [ml], mean ± sd | 10.1 ± 11.9 | 25.1 ± 31.2 | < .001 |
Single dose [Gy], mean ± sd | 5.2 ± 0.9 | 1.8 ± 0.1 | < .001 |
Single dose [Gy], median (range) | 5.0 (2.67–8) | 1.8 (1.8–2.8) | |
Total dose [Gy], mean ± sd | 24.6 ± 4.9 | 56.9 ± 4.2 | < .001 |
Total dose [Gy], median (range) | 25 (15–61) | 59.4 (32.4–63) | |
Prescription isodose [%], mean ± sd | 75.6 ± 5.3 | 95 ± 0 | < .001 |
Prescription isodose [%], median (range) | 75.0 (60.0–100.0) | 95 (95–95) | |
EQD2 [Gy], mean ± sd | 44.1 ± 8.1 | 54. 2 ± 3.8 | < .001 |
EQD2 [Gy], median (range) | 43.8 (26.3–100.0) | 56.43 (30.78–60) | |
BED [Gy], mean ± sd | 88.1 ± 16.3 | 108.5 ± 7.5 | < .001 |
BED [Gy], median (range) | 87.5 (52.5–200) | 112.9 (61.6–120) |